Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
41.84
+0.06 (0.14%)
Sep 26, 2025, 4:08 PM HKT
Market Cap 19.11B
Revenue (ttm) 61.85M
Net Income (ttm) -243.14M
Shares Out 456.82M
EPS (ttm) -0.58
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 458,200
Average Volume 553,586
Open 41.82
Previous Close 41.78
Day's Range 41.00 - 42.18
52-Week Range 40.08 - 74.00
Beta n/a
RSI 32.26
Earnings Date Aug 29, 2025

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in development of drugs. Its products are used for treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. Guangzhou Innogen Group Co., Ltd. operates as a subsidiary of KPC Pharmaceuticals, Inc. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 105
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.